Nexalin Technology (NXL) Receivables (2021 - 2026)
Nexalin Technology (NXL) recorded quarterly Receivables of $43004.0 in Q1 2026, down 47.28% quarter-over-quarter from $81571.0 in Q4 2025, and up 197.01% on a YoY basis from $14479.0 in Q1 2025.
Nexalin Technology (NXL) Receivables (2021 - 2026) Analysis & Trends
Nexalin Technology's Receivables history runs 6 years deep, the most recent figure standing at $43004.0 for Q1 2026.
- In Q1 2026, Receivables rose 197.01% year-over-year to $43004.0; the TTM figure through Mar 2026 stood at $43004.0 (up 197.01% YoY), while the FY2025 annual figure was $81571.0, up 525.4% from the prior year.
- Receivables was $43004.0 for Q1 2026 at Nexalin Technology, down from $81571.0 in the prior quarter.
- In the past five years, Receivables ranged from a high of $81571.0 in Q4 2025 to a low of $3550.0 in Q1 2023.
- Historically, Receivables has averaged $20952.2 across 5 years, with a median of $14322.0 in 2023.
- The sharpest annual moves came in 2022 and 2025: Receivables tumbled 70.1% in 2022, then soared 525.4% in 2025.
- A 5-year view of Receivables shows it stood at $4875.0 in 2022, then surged by 92.18% to $9369.0 in 2023, then surged by 39.21% to $13043.0 in 2024, then jumped by 525.4% to $81571.0 in 2025, then tumbled by 47.28% to $43004.0 in 2026.
- The last three Receivables figures came in at $43004.0 (Q1 2026), $81571.0 (Q4 2025), and $7925.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 8.21 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 3.57 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 6.36 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 3.15 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 973.00 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 3.82 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 1.11 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 4.50 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 1.09 Bn |
| 10 | Nexalin Technology | 7.82 Mn | 5.11 Mn | 13,133.00 | 43,004.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 43,004.00 |
| Dec 31, 2025 | 81,571.00 |
| Sep 30, 2025 | 7,925.00 |
| Jun 30, 2025 | 59,841.00 |
| Mar 31, 2025 | 14,479.00 |
| Dec 31, 2024 | 13,043.00 |
| Sep 30, 2024 | 15,171.00 |
| Jun 30, 2024 | 11,720.00 |
| Mar 31, 2024 | 3,666.00 |
| Dec 31, 2023 | 9,369.00 |
| Sep 30, 2023 | 14,483.00 |
| Jun 30, 2023 | 14,322.00 |
| Mar 31, 2023 | 3,550.00 |
| Dec 31, 2022 | 4,875.00 |
| Sep 30, 2022 | 17,264.00 |
| Dec 31, 2021 | 16,303.00 |